MSB 7.69% $1.19 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-486

  1. 30,316 Posts.
    lightbulb Created with Sketch. 1836
    If they don't, the Courts will sort them out. This is the beauty of having those precedents under our belt.

    The best way is for the FDA to save time and face and reverse their position. If they don't, it will be drawn out and we will make them look like idiots. IMO.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.